Implications of gene-behavior interactions: Prevention and intervention for obesity

Obesity

Volumn 16, Issue SUPPL. 3, 2008, Pages

  Bray, Molly S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY WEIGHT; CALORIC INTAKE; ENERGY METABOLISM; ENVIRONMENT; FEEDING BEHAVIOR; GENETIC VARIABILITY; GENETICS; HUMAN; NUTRIGENOMICS; OBESITY; PHYSIOLOGY;

BODY WEIGHT; ENERGY INTAKE; ENERGY METABOLISM; ENVIRONMENT; FEEDING BEHAVIOR; GENETIC VARIATION; HUMANS; NUTRIGENOMICS; OBESITY;

EID: 56849116723     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.522     Document Type: Article

References (95)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
2. Freedman DS, Khan LK, Serdula MK, Ogden CL, Dietz WH. Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity 2006;14:301-308.
3. Services, USDoHaH, 1998 National Health Interview Survey (NHIS). U.S. Department of Health and Human Services: Hyattsville, MD, 2000.
4. Kruger J, Galuska DA, Serdula MK, Jones DA. Attempting to lose weight: specific practices among U.S. adults. Am J Prev Med 2004;26:402-406.
5. Davis RB, Turner LW. A review of current weight management: research and recommendations. J Am Acad Nurse Pract 2001;13:15-19.
6. Irving LM, Neumark-Sztainer D. Integrating the prevention of eating disorders and obesity: feasible or futile? Prev Med 2002;34:299-309.
7. Jeffery R, Drewnowski A, Epstein L et al. Long-term maintenance of weight loss: current status. Health Psychol 2000; 19:5-16.
8. Franz MJ, Vanwormer JJ, Crain AL et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. JAm Diet Assoc 2007;107:1755-1767.
9. Anderson, LA, Eyler AA, Galuska DA, Brown DR, Brownson RC. Relationship of satisfaction with body size and trying to lose weight In a national survey of overweight and obese women aged 40 and older, United States. Prev Med 2002;35:390-396.
10. Teixeira PJ, Going SB, Houtkooper LB et al. Exercise motivation, eating, and body Image variables as predictors of weight control. Med Sci Sports Exerc 2006;38:179-188.
11. Hague AL, White AA. Web-based Intervention for changing attitudes of obesity among current and future teachers. J Nutr Educ Behav 2005;37:58-66.
12. Sugerman HJ, Kellum JM, Engle KM et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992;55:560S-566S.
13. Brethauer, SA, Nfonsam V, Sherman V, Udomsawaengsup S, Schauer PR, Chand B. Endoscopy and upper gastrointestinal contrast studies are complementary In evaluation of weight regain after bariatric surgery. Surg Obes Relat Dis 2006;2:643-648.
14. MacLean L, Rhode B. Does genetic predisposition influence surgical results of operations for obesity? Obes Surg 1996;6:132-137.
15. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes Relat Metab Disord 2003;27:1437-1446.
16. Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E. Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999;106:179-184.
17. de Simone G, Romano C, De Caprio C et al. Effects of sibutramine-induced weight loss on cardiovascular system In obese subjects. Nutr Metab Cardiovasc Dis 2005;15:24-30.
18. Hung YJ, Chen YC, Pel D et al. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with type 2 diabetes. Diabet Med 2005;22:1024-1030.
19. Berkowitz RI, Fujioka K, Daniels SR et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 2006;145:81-90.
20. Hauner H, Meier M, Jockel KH, Frey UH, Siffert W. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 2003;13:453-459.
21. Zhang Y, Proenca R, Maffel M, Barone, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
22. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
23. Frederich, RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1:1311-1314.
24. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
25. Maffei M, Halaas J, Ravussin E et al. Leptin levels In human and rodent: measurement of plasma leptin and ob RNA In obese and weight-reduced subjects. Nat Med 1995;1:1155-1161.
26. Pellymounter MA, Cullen MJ, Baker MB et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995:269:540-543.
27. Lonnqvist F, P Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1995;1:950-953.
28. Hamilton BS, Paglia D, Kwan AYM, Dietel M. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995;1:953-956.
29. Ahima RS. Central actions of adipocyte hormones, Trends Endocrinol Metab 2005;16:307-313.
30. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin, Science 1996;274:1185-1188.
31. Mueller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997;272:10585-10593.
32. Muoio D, Dohn G, Fiedorek F, Tapscott E, Coleman R. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997;46:1360-1363.
33. Chen G, Koyama K, Yuan X et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 1996:93:14795-14799.
34. Collins S, Kuhn C, Petro A, Swick A, Chrunyk B, Surwit R. Role of leptin in fat regulation. Nature 1996;380:677.
35. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22.
36. Banks W, Kastin A, Huang W, Jaspan J, Maness L. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
37. Zamorano P, Mahesh V, DeSevilla L, Chorich L, Bhat G, Brann D. Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat. Neuroendocrinology 1996;65:223-228.
38. Elmquist J. Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin. Int J Obes Relat Metab Disord 2001;25:S78-S82.
39. Nogueiras R, Wiedmer P, Perez-Tilve D et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007;117:3475-3488.
40. Raposinho PD, White RB, Aubert ML. The melanocortin agonist melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. J Neuroendocrinol 2003; 15:173-181.
41. Ste Marie L, Miura Gl, Marsh DJ, Yagaloff K, Palmiter RD. A metabolic defect promotes obesity In mice lacking melanocortin-4 receptors. Proc Natl Acad Sci USA 2000;97:12339-12344.
42. Prins JB, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Colch) 1997;92:3-11.
43. Miller WH, Jr, Faust IM, Goldberger AC, Hirsch J. Effects of severe long-term food deprivation and refeeding on adipose tissue cells in the rat. Am J Physiol 1983;245:E74-E80.
44. Prins JB, Walker NI, Winterford CM, Cameron DP. Human adipocyte apoptosis occurs In malignancy. Biochem Biophys Res Commun 1994;205:625-630.
45. Oswal A, Yeo GS. The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics, Obes Rev 2007;8:293-306.
46. Hainerova I. [Obesity based on mutation of genes involved in energy balance]. Cas Lek Cesk 2007;146:240-245.
47. Shimizu H, Inoue K, Mori M. The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol 2007;193:1-9.
48. O'Rahilly S. Human obesity and insulin resistance: lessons from experiments of nature. Biochem Soc Trans 2007;35:33-36.
49. Mutch DM, Clement K. Unraveling the genetics of human obesity. PLoS Genet 2006;2:e188.
50. Farooqi S, O'Rahilly S. Genetics of obesity in humans. Endocr Rev 2006;27:710-718.
51. Mietus-Snyder ML, Lustig RH. Childhood obesity: adrift in the "limbic triangle". Annu Rev Med 2008;59:147-162.
52. Montague C, Farooql S, Whitehead J et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
53. Strobel A, Issad T, Camoin L, Ozata M, Strosberg A. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-215.
54. Clement K, Vaisse C, Lahlou N et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
55. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-157.
56. O'Rahilly S, Gray H, Humphreys PJ et al. Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. New Eng J Med 1995;333:1386-1390.
57. Yeo GSH, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998;20:111-112.
58. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998;20:113-114.
59. Hinney A, Schmidt A, Nottebom K et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocr Metab 1999;84:1483-1486.
60. Farooqi I, Yeo G, Keogh J et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000;106:271-279.
61. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262.
62. Govaerts C, Srinivasan S, Shapiro A et al. Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function. Peptides 2005;26:1909-1919.
63. Borecki IB, Rice T, Bouchard C, Rao DC. Commingling analysis of generalized body mass and composition measures: The Quebec Family Study. Int J Obes 1991;15:763-773.
64. Rice T, Borecki IB, Bouchard C, Rao DC. Segregation analysis of fat mass and other body composition measures derived from underwater weighing. Am J Hum Genet 1993;52:967-973.
65. Comuzzie A, Blangero J, Mahaney M et al. Major gene with sex-specific effects influences fat mass in Mexican Americans. Genet Epidemiol 1995:12:475-488.
66. Bouchard C, Rice T, Lemieux S, Despres J-P, Perusse L, Rao D. Major gene for abdominal visceral fat area in the Quebec Family Study. Int J Obes 1996;20:420-427.
67. Moll PP, Burns TL, Lauers RM. The genetic and environmental sources of body mass index variability: the Muscatine Ponderosity Family Study. Am J Hum Genet 1991 ;49:1243-1255.
68. Bouchard C, Tremblay A, Despres J et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990;322:1477-1482.
69. Koplan J, Liverman C, Kraak V. Committee on Prevention of Obesity in Children and Youth, Food and Nutrition Board, Board on Health Promotion and Disease Prevention, Institute of Medicine. Preventing Childhood Obesity: Health in the Balance. National Academies Press: Washington, DC, 2005.
70. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: the 2005 update. Obesity 2006;14:529-644.
71. Bouchard C. The biological predisposition to obesity: beyond the thrifty genotype scenario. Int J Obes 2007;31:1337-1339.
72. Mammes O, Betoulle D, Aubert R et al. Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes 1998;47:487-489.
73. Mammes O, Betoulle D, Aubert R, Herbeth B, Siest G, Fumeron F. Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight. Ann Hum Genet 2000;64:391-394.
74. Mammes O, Aubert R, Betoulle D et al. LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest 2001;31:398-404.
75. de Luis Roman D, de la Fuente RA, Sagrado MG, Izaola O, Vicente RC. Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch Med Res 2006;37:854-859.
76. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MI. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 2001;44:925-926.
77. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001;50:2172-2176.
78. Grove ML, Morrison A, Folsom AR, Boerwinkle E, Hoelscher DM, Bray MS. Gene-environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities Study. Int J Obes 2007;31:919-926.
79. Danoviz ME, Pereira AC, Mill JG, Krieger JE. Hypertension, obesity and GNB 3 gene variants. Clin Exp Pharmacol Physiol 2006;33:248-252.
80. Potoczna N, Wertli M, Steffen R, Ricklin T, Lentes KU, Horber FF. G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients. J Gastrointest Surg 2004;8:862-868.
81. Rankinen T, Perusse L, Rauramaa R, Rivera MA, Wolfarth B, Bouchard C. The human gene map for performance and health-related fitness phenotypes. Med Sci Sports Exerc 2001;33:855-867.
82. Wolfarth B, Bray MS, Hagberg JM et al. The human gene map for performance and health-related fitness phenotypes: the 2004 update. Med Sci Sports Exerc 2005;37:881-903.
83. Subbiah MT. Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine. Transl Res 2007:149:55-61.
84. Ferguson LR. Nutrigenomics: itegrating genomic approaches into nutrition research. Mol Diagn Ther 2006;10:101-108.
85. Koch RK. Issues in newborn screening for phenylketonuria. Am Fam Physician 1999;60:1462-1466.
86. Adamo KB, Dent R, Langefeld CD et al. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity 2007;15:1068-1075.
87. Sakane N, Yoshida T, Umekawa T, Kogure A, Takakura Y, Kondo M. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care 1997;20:1887-1890.
88. Shiwaku K, Nogi A, Anuurad E et al. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int J Obes Relat Metab Disord 2003;27:1028-1036.
89. Fumeron F, Durack-Bown I, Betoulle D et al. Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord 1996;20:1051-1054.
90. Sesti G, Perego L, Cardellini M et al. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet J Clin Endocrinol Metab 2005;90:5064-5069.
91. Goyenechea E, Dolores Parra M, Alfredo Martinez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br J Nutr 2006;96:965-972.
92. Santoro N, Perrone L, Cirillo G et al. Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr 2007;85:950-953.
93. Corella D, Qi L, Sorli JV et al. Obese subjects carrying the 11482G>A polymorphism at the perillpin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metab 2005;90:5121-5126.
94. Chen HH, Lee WJ, Wang W, Huang MT, Lee YC, Pan WH. Ala55Val polymorphism on UCP2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding. Obes Surg 2007;17:926-933.
95. Cha MH, Shin HD, Kim KS, Lee BH, Yoon Y. The effects of uncoupling protein 3 haplotypes on obesity phenotypes and very low-energy diet-induced changes among overweight Korean female subjects, Metabolism 2006;55:578-586.